18876-89-6 Usage
General Description
N,N-diMethyl-N'-(thiazol-2-yl)forMaMidine, also known as thiamethoxam, is a neonicotinoid insecticide used in agriculture to control a variety of pests. It works by disrupting the nervous system of insects, leading to paralysis and eventual death. Thiamethoxam is commonly used on a wide range of crops, including corn, soybeans, and cotton, to protect them from harmful insects such as aphids, beetles, and thrips. However, there has been concern about its potential impact on pollinators, such as bees, and its potential for environmental persistence and accumulation. As a result, thiamethoxam's use has been restricted or banned in some regions, and its use is subject to regulations and monitoring.
Check Digit Verification of cas no
The CAS Registry Mumber 18876-89-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,8,7 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 18876-89:
(7*1)+(6*8)+(5*8)+(4*7)+(3*6)+(2*8)+(1*9)=166
166 % 10 = 6
So 18876-89-6 is a valid CAS Registry Number.
18876-89-6Relevant articles and documents
3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 43, (2010/02/17)
The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.
TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 79, (2009/03/07)
The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.
2-CYCLOPROPYL-THIAZOLE DERIVATIVES
-
Page/Page column 49-50, (2009/01/20)
The invention relates to selected 2-cyclopropyl-thiazole derivatives of the formula (I) wherein B, Y and R1 are as described in the description; to salts and especially pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.
